Evidence map›Paper›PMID 35573704›Full record

ReviewFrontiers in cell and developmental biology2022

The ER-Mitochondria Interface as a Dynamic Hub for T Cell Efficacy in Solid Tumors.

Elizabeth G Hunt, Alex M Andrews, Sydney R Larsen, Jessica E Thaxton

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Next Generation Calcium Nanomaterials: Disrupting Tumor CaInternational journal of nanomedicine · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Elizabeth G HuntImmunotherapy Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States.
Alex M AndrewsHollings Cancer Center, Charleston, SC, United States.
Sydney R LarsenAmherst College, Amherst, MA, United States.
Jessica E ThaxtonImmunotherapy Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States.
University of North Carolina at Chapel Hill · USAmherst College · USMedical University of South Carolina · US

Funding

Targeting Chronic ER Stress in T Cells to Improve Cancer ImmunotherapyR01CA244361 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI THAXTON, JESSICA E · 2020 to 2024
$1.9M
Expoitation of ER Stress Induced Immune Dysfunction to Improve ImmunotherapyR01CA248359 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI THAXTON, JESSICA E · 2020 to 2024
$1.7M
NCI NIH HHS R01 CA244361NCI NIH HHS R01 CA248359
6 · The paper itself

Abstract

The endoplasmic reticulum (ER) is a large continuous membranous organelle that plays a central role as the hub of protein and lipid synthesis while the mitochondria is the principal location for energy production. T cells are an immune subset exhibiting robust dependence on ER and mitochondrial function based on the need for protein synthesis and secretion and metabolic dexterity associated with foreign antigen recognition and cytotoxic effector response. Intimate connections exist at mitochondrial-ER contact sites (MERCs) that serve as the structural and biochemical platforms for cellular metabolic homeostasis through regulation of fission and fusion as well as glucose, Ca

Indexed as

cancer immunotherapyendoplasmic recticulum (ER)ER stressMERCsmetabolismT celltumor microenvironment

Identifiers

PMID35573704
PMCPMC9091306
OpenAlexW4224940381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.